MLPA can detect deletions when the proportion of patient DNA known to harbor deletions is 60% or greater
| . | ASS . | PRDM12 . | EXOSC2 . | ABL exon 1 . | BCR exon 16 . | FLJ31568 . |
|---|---|---|---|---|---|---|
| 100% | del | del | del | del | del | del |
| 80% | del | del | del | del | del | del |
| 60% | del | del | del | del | del | del |
| 40% | del | + | del | del | + | + |
| 20% | + | + | del | + | + | + |
| 0% | + | + | + | + | + | + |
| . | ASS . | PRDM12 . | EXOSC2 . | ABL exon 1 . | BCR exon 16 . | FLJ31568 . |
|---|---|---|---|---|---|---|
| 100% | del | del | del | del | del | del |
| 80% | del | del | del | del | del | del |
| 60% | del | del | del | del | del | del |
| 40% | del | + | del | del | + | + |
| 20% | + | + | del | + | + | + |
| 0% | + | + | + | + | + | + |
At 60% patient DNA and over, all 6 markers are correctly scored as deleted, whereas at lower dilutions, deletions are often missed.
+ indicates not deleted (dosage quotient ≥ 0.7); del, deleted (dosage quotient < 0.7).